Poliovirus Vaccine Inactivated
drugOn this page
Also known as Poliomyelitis vaccine
Summary
Poliovirus Vaccine Inactivated (CHEMBL2107962) is a phase-3 clinical-stage vaccine component; indicated across 7 conditions including viral infectious disease and poliomyelitis.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Vaccine component
- Indications: 7 conditions
- Clinical trials: 2
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2107962 |
| Name | Poliovirus Vaccine Inactivated |
| Type | Vaccine component |
| Max phase | 3 |
Also known as: Poliomyelitis vaccine, Poliovirus vaccine inactivated, POLIOVIRUS VACCINE INACTIVATED
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
7 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| viral infectious disease | 3 | MONDO:0005108 | EFO:0000763 |
| poliomyelitis | 3 | MONDO:0017373 | EFO:0007450 |
| Rotavirus infection | 3 | MONDO:0005194 | EFO:0002622 |
| meningococcal infection | 3 | MONDO:0005373 | EFO:0004249 |
| gastroenteritis | 3 | MONDO:0002269 | EFO:1001463 |
| postpoliomyelitis syndrome | 2 | MONDO:0017416 | EFO:0007454 |
| malaria | 1 | MONDO:0005136 | EFO:0001068 |
Clinical trials
Total trials: 2.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE3 | 1 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06397768 | PHASE3 | TERMINATED | Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers |
| NCT01056705 | PHASE2 | COMPLETED | The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV) |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).